Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,896.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 2,120.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 350,964
  • Market Cap: £4,206.97m
  • RiskGrade: 125

Tuesday broker round-up

By Caoimhe Toman

Date: Tuesday 30 Oct 2018

LONDON (ShareCast) - (Sharecast News) - Inmarsat: Numis upgrades to hold with a target price of 430p.
Watkin Jones: Berenberg initiates at buy with a target price of 235p.

Amigo Holdings: Berenberg initiates at hold with a target price of 240p.

RDI REIT: Berenberg reiterates buy with a target price of 40p.

Computacenter: Berenberg reiterates buy with a target price of 1,850p.

HSBC: Deutsche Bank reiterates hold with a target price of 718p.

BP: RBC Capital Markets reiterates top pick with a target price of 700p.

Serco: Peel Hunt reiterates reduce with a target price of 87p.

Weir Group: Peel Hunt reiterates buy with a target price of 2,450p.

Hikma Pharmaceuticals: Citigroup reiterates buy with a target price of 2,250p.

HSBC: Citigroup downgrades to neutral with a target price of 660p.

Reckitt Benckiser: Liberum reiterates buy with a target price of 7,600p.

Sage: Canaccord upgrades to hold with a target price of 540p.

Playtech: Credit Suisse reiterates neutral with a target price of 520p.

GVC Holdings: Credit Suisse reiterates outperform with a target price of 1,080p.

Hastings: Numis downgrades to add with a target price of 220p.

Travis Perkins: Barclays upgrades to equal weight with a target price of 1,150p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,896.00p
Change Today 19.00p
% Change 1.01 %
52 Week High 2,120.00
52 Week Low 1,722.00
Volume 350,964
Shares Issued 221.89m
Market Cap £4,206.97m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.84% below the market average43.84% below the market average43.84% below the market average43.84% below the market average43.84% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Price Trend
19.79% above the market average19.79% above the market average19.79% above the market average19.79% above the market average19.79% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
16.04% above the market average16.04% above the market average16.04% above the market average16.04% above the market average16.04% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 15-Aug-24 21-Mar-24
Paid 20-Sep-24 03-May-24
Amount 32.00¢ 47.00¢

Trades for 27-Sep-2024

Time Volume / Share Price
17:19 146,027 @ 1,882.00p
16:53 411 @ 1,896.00p
16:53 2,246 @ 1,896.00p
16:35 266 @ 1,896.00p
16:35 153,088 @ 1,896.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page